Loading...

Amicus Therapeutics, Inc.

0HF9.L•LSE
Healthcare
Medical - Pharmaceuticals
£7.49
£-0.04(-0.60%)

Amicus Therapeutics, Inc. (0HF9.L) Stock Overview

Explore Amicus Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.0/100

Key Financials

Market Cap2.2B
P/E Ratio-60.39
EPS (TTM)$-0.97
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 Week$6.16
1 Month$6.00
3 Months$7.30
1 Year Target$8.99

0HF9.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amicus Therapeutics, Inc. (0HF9.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.15, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $8.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -60.39 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.93%
5-Day Change
-20.08%
1-Month Change
-28.16%
3-Month Change
-29.62%
6-Month Change
-38.73%
Year-to-Date (YTD) Change
-33.58%
1-Year Change
-44.10%
3-Year Change
-26.21%
5-Year Change
-34.49%
All-Time (Max) Change
-34.49%

Contact Information

https://amicusrx.com
215 921 7600
3675 Market Street, Philadelphia, PA, 19104

Company Facts

499 Employees
IPO DateJan 29, 2018
CountryUS
Actively Trading

Frequently Asked Questions

;